McElrath MJ - Search Results

1

Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype.

Dinges WL, Richardt J, Friedrich D, Jalbert E, Liu Y, Stevens CE, Maenza J, Collier AC, Geraghty DE, Smith J, Moodie Z, Mullins JI, McElrath MJ, Horton H. Dinges WL, et al. Among authors: mcelrath mj. J Virol. 2010 May;84(9):4461-8. doi: 10.1128/JVI.02438-09. Epub 2010 Feb 10. J Virol. 2010. PMID: 20147397 Free PMC article.

2

Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.

Malhotra U, Holte S, Zhu T, Delpit E, Huntsberry C, Sette A, Shankarappa R, Maenza J, Corey L, McElrath MJ. Malhotra U, et al. Among authors: mcelrath mj. J Virol. 2003 Feb;77(4):2663-74. doi: 10.1128/jvi.77.4.2663-2674.2003. J Virol. 2003. PMID: 12552005 Free PMC article.

3

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity.

Russell ND, Hudgens MG, Ha R, Havenar-Daughton C, McElrath MJ. Russell ND, et al. Among authors: mcelrath mj. J Infect Dis. 2003 Jan 15;187(2):226-42. doi: 10.1086/367702. Epub 2003 Jan 6. J Infect Dis. 2003. PMID: 12552447

4

Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.

Zhu T, Corey L, Hwangbo Y, Lee JM, Learn GH, Mullins JI, McElrath MJ. Zhu T, et al. Among authors: mcelrath mj. J Virol. 2003 Jun;77(11):6108-16. doi: 10.1128/jvi.77.11.6108-6116.2003. J Virol. 2003. PMID: 12743268 Free PMC article.

5

Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.

Cao J, McNevin J, Holte S, Fink L, Corey L, McElrath MJ. Cao J, et al. Among authors: mcelrath mj. J Virol. 2003 Jun;77(12):6867-78. doi: 10.1128/jvi.77.12.6867-6878.2003. J Virol. 2003. PMID: 12768006 Free PMC article.

6

HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals.

Musey L, Ding Y, Elizaga M, Ha R, Celum C, McElrath MJ. Musey L, et al. Among authors: mcelrath mj. J Immunol. 2003 Jul 15;171(2):1094-101. doi: 10.4049/jimmunol.171.2.1094. J Immunol. 2003. PMID: 12847284 Clinical Trial.

7

Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells.

Hladik F, Desbien A, Lang J, Wang L, Ding Y, Holte S, Wilson A, Xu Y, Moerbe M, Schmechel S, McElrath MJ. Hladik F, et al. Among authors: mcelrath mj. J Immunol. 2003 Sep 1;171(5):2671-83. doi: 10.4049/jimmunol.171.5.2671. J Immunol. 2003. PMID: 12928421

8

Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.

Cao J, McNevin J, Malhotra U, McElrath MJ. Cao J, et al. Among authors: mcelrath mj. J Immunol. 2003 Oct 1;171(7):3837-46. doi: 10.4049/jimmunol.171.7.3837. J Immunol. 2003. PMID: 14500685

9

Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease.

Malhotra U, Bosch RJ, Chan E, Wang R, Fischl MA, Collier AC, McElrath MJ. Malhotra U, et al. Among authors: mcelrath mj. J Infect Dis. 2004 Feb 1;189(3):515-9. doi: 10.1086/381038. Epub 2004 Jan 16. J Infect Dis. 2004. PMID: 14745710 Clinical Trial.

10

Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials.

Hudgens MG, Self SG, Chiu YL, Russell ND, Horton H, McElrath MJ. Hudgens MG, et al. Among authors: mcelrath mj. J Immunol Methods. 2004 May;288(1-2):19-34. doi: 10.1016/j.jim.2004.01.018. J Immunol Methods. 2004. PMID: 15183082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters